Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M. STRAMA, Swedish Institute for Infectious.

Slides:



Advertisements
Similar presentations
European Centre for Disease Prevention and Control
Advertisements

Antibiotic policy to prevent resistance development Inga Odenholt Associate professor Department of Infectious Diseases, Malmö Lund University, Sweden.
Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M STRAMA, Swedish Institute for Infectious.
When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.
+ A Vitamin T Overdose? : An audit of piperacillin/ tazobactam use at Royal Perth Hospital Amelia Davis and Matthew Hanson Contributors: Dr Susan Benson,
Judicious Antibiotic Use in Developing Countries Global Missions Health Conference Louisville, KY Nov. 9, 2012 Ron Herman, Ph.D.
Pneumonia & Respiratory Tract Infection: Antibiotic risk for Clostridium difficile Kieran Hand*, Adil Ahmed †, Adriana Basarab ¶, Whitney Chow †, Nick.
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
Information for Action Point Prevalence Survey of Healthcare associated infection and antimicrobial use 26 th June 2012 Dafydd Williams.
“Influence of age on the management of heart failure: Findings from Get With the Guidelines–Heart Failure (GWTG-HF)” Daniel E. Forman, MD; Christopher.
Use of antibiotics. Antibiotic use Antimicrobials are the 2 nd most common drugs prescribed by office based physicians In USA1992: 110 million oral antimicrobial.
Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases National Heart, Lung, and Blood Institute February, 2012.
Antibiotic Prescribing Practices of Primary Care Prescribers for Acute Respiratory Tract Infections and Diarrhoea in New Delhi, India Anita Kotwani 1,
Key Strategies for Improving Use of Existing and New Antibiotics -the European Experience Otto Cars Professor Inf. Diseases, Uppsala University, Sweden.
Improving Antibiotic use through a Nationwide Decentralized Project – A Nine-Year Experience Cars O, Stålsby Lundborg C, Mölstad S Swedish Strategic Programme.
Severity assessment for lower respiratory tract infections: potential use and validity of CRB-65 in primary care N. Francis, J. Cals, C. Butler, K. Hood,
Point Prevalence Survey of Hospital- Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2012 Background & Introduction.
Journal of the Pediatric Infectious Diseases Society Advance Access published June 2, 2014.
Erntell M, Skoog G, Cars O, Eriksson M, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P. STRAMA, Swedish Institute.
DEPARTMENT OF HEALTH DOTS Program for TB (Tuberculosis Directly Observed Short-course)
Lessons Learned in Abx. Stewardship: Fluoroquinolone Use in Pediatrics Division of Pediatric Infectious Diseases, Department of Pediatrics, University.
The Swedish Experience Otto Cars Prof. Infectious Diseases Uppsala University Hospital Sweden.
Collecting data in clinic.  Aim of BADBIR  Definition of Adverse Events  Adverse events in BADBIR  Adverse event recording in hospital case notes.
Probiotics May Lower Risk for Nosocomial Infections in Hospitalized Children A randomized, double-blind, placebo-controlled trial reported in the May issue.
A parent brings her two year old son to your office because of a chief complaint of fussiness and tugging at his right ear for the past two days. He.
Medications for the Treatment of Infections. Antibiotic vs. Antibacterial Used interchangeably Origin of antibiotic includes any antimicrobial agent Antibacterial.
Variation in service-providers’ prescribing behaviour and policy implications for women with genitourinary tract infections in Ramallah, occupied Palestinian.
Incidence of hospitalisations in both groups Incidence of documented infections Abstract Problem statement: Patients on cancer chemotherapy are at substantial.
Bacterial Pneumonia.
Swedres 2005 Swedres 2005 Figures and tables. Swedres 2005 Table Total use of antibacterial drugs for systemic use in Sveden , DDD/1000/day.
CLINICAL PHARMACOLOGY OF ANTIBACTERIAL AGENTS. Actions of antibacterial drugs on bacterial cells.
An Intervention To Improve Antibiotic Prescribing Habits of Doctors in a Teaching Hospital Ofei F, Forson A, Tetteh R, Ofori-Adjei D University of Ghana.
1 EFFICACY OF SHORT COURSE AMOXICILLIN FOR NON-SEVERE PNEUMONIA IN CHILDREN (Hazir T*, Latif E*, Qazi S** AND MASCOT Study Group) *Children’s Hospital,
Cheryl Meddles-Torres, DNP, RN, FNP-C Shuang Hu
Antimicrobials - Quinolones & Fluoroquinolones Antimicrobials - Quinolones & Fluoroquinolones Pharmacology -1 DSX 215 DSX 215 Dr/ Abdulaziz Saeedan Pharmacy.
ANTIBIOTIC USE IN PATIENTS WITH FEVER OF UNKNOWN ORIGIN (FUO) AT PANTI RAPIH HOSPITAL YOGYAKARTA-INDONESIA Hartayu T 1, Asdie HAH 2, Suryawati S 3 1 Faculty.
15/03/2016Specialised psychiatric care Sami Fredriksson & Simo Pelanteri.
Antibiotic utilization in general medical units in a tertiary care institution Fernando GVMC, Ratnasekera IU, Perera MSD, Wanigatunge CA.
Tigecycline use in serious nosocomial infections: a drug use evaluation Matteo Bassetti*, Laura Nicolini, Ernestina Repetto, Elda Righi, Valerio Del Bono,
Harm from Invasive Devices Dr. Eleri Davies, Faculty Lead HCAI.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 07- Penicillins.
Northern Dimension Antibiotic Resistance Study NoDARS Prof Jaana Vuopio, M.D., Ph.D., PAC 11 side-event, 19 November 2015, Berlin, Germany.
The AHRQ Safety Program for Improving Antibiotic Use
Antibiotic use and bacterial complications following upper respiratory tract infections: a population based study.
Table 3 Clinical response success rate, according to prior effective antimicrobial therapy in hospitalized patients with community-acquired pneumonia given.
„ Can we change doctor’s prescribing antibiotic habits? “
Antibiotics: handle with care!
Use of antibiotics.
Systemic antibiotic treatment in upper and lower respiratory tract infections: official French guidelines  Agence Française de Sécurité, Sanitaire des.
Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted.
The AHRQ Safety Program for Improving Antibiotic Use
ABSTRACT Problem statement: The Lao PDR National Drug Policy (NDP) Program, implemented by the Ministry of Health supported by the Swedish International.
Networks of hospitals: building a common strategy for HAI prevention and control and antimicrobial policy Tomasz Ozorowski, M.D. University of Medical.
The AHRQ Safety Program for Improving Antibiotic Use
Patterns of asthma medications prescriptions among adult patients in the chest and accident and emergency units of a tertiary health care facility in Uganda.
Trap B and Hansen EH Euro Health Group, Denmark &
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Hospital Antibiotic Stewardship Programs
Jessina C. McGregor, PhD; Miriam R. Elman, MPH; David T
Tenaw & Tsige, Self-medication, Ethiopia
Systemic antibiotic treatment in upper and lower respiratory tract infections: official French guidelines  Agence Française de Sécurité, Sanitaire des.
GLOBAL POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION AND RESISTANCE (GLOBAL-PPS): RESULTS OF ANTIMICROBIAL PRESCRIBING IN INDIA Dr. Sanjeev K Singh.
Improving Antibiotic use through a Nationwide Decentralized Project –
Presentation Title 36pt Arial Bold
G. Höffken  Clinical Microbiology and Infection 
Tony Crockford & Muhammad Sartaj.
INFECTIOUS DISEASES CLERKSHIP –
AHRQ Safety Program for Improving Antibiotic Use
Mar Pujades-Rodriguez, Robert M. West, Mark H. Wilcox, Jonathan Sandoe
Presentation transcript:

Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M. STRAMA, Swedish Institute for Infectious Disease Control, S Solna, Sweden POINT PREVALENCE STUDIES (PPS) OF ANTIMICROBIAL USE IN SWEDISH HOSPITALS, 2003 AND 2004 Introduction and purpose Data revealing antibiotic consumption and prescription patterns related to diagnose at the patient level is essential in finding ways to optimize antibiotic use in the hospital setting. We present data from the first nation wide point prevalence studies, PPS, performed in Sweden. Methods The studies were performed within a two-week period in November 2003 and 2004 by the local STRAMA-groups using a web-based reporting system. Each department had one personal visit of an experienced doctor collecting data. The protocol was designed to present demographic data as well as the amounts and indications for antimicrobial agents against bacteria and fungi. Treatments were recorded in relation to diagnose and the therapeutic indication as either prophylactic use or treatment of community acquired and hospital acquired infection. 19 pre-defined diagnosis groups were used. Results Results from the 333 hospital departments participating in both PPS 2003 and 2004 are presented below. Distribution of therapy reasons in treated patients Antimicrobials in DDD/100 admitted adult patients in different specialities Number of admitted patients, 2003/2004, in brackets Distribution of antimicrobials for treatment and prophylaxis. Pooled data from both studies. Distribution of antimicrobials in treatment of community acquired pneumonia Distribution of antimicrobials in treatment of lower urinary tract infection in women Proportion of peri-operative prophylaxis prescribed for >24 hours in some surgical specialities Total number of therapies, 2003/2004, in brackets Conclusions The PPS method was successfully introduced and has been an important tool to identify problem areas of antimicrobial hospital treatments. Cephalosporins were over-used in community acquired infections as pneumonia and skin and soft tissue infections A large fraction of women with cystitis were treated with fluoroquinolones Peri-operative prophylaxis was too long, >24 hours in over 40% of therapies Abstract Background and Objective: The objective of the study was to introduce a nation wide survey system for frequent assessment of the use of antimicrobial agents in relation to diagnose. Design: Two PPS with one personal visit to each department were performed within a two- week period in November 2003 and The protocol was designed to present demographic data as well as the amounts and indications for antimicrobial agents against bacteria and fungi. Treatments were recorded in relation to diagnose and therapy reason (community acquired (CAI) or hospital acquired infection (HAI)). 19 pre-defined diagnosis groups were used. Prophylactic use was recorded in relation to prescribed doses. DDDs were calculated according to the WHO standard. A web-based reporting system was used to collect the data. Setting: Swedish hospitals, 31 different specialities. Main outcome measures: Antimicrobial use, in DDDs, in relation to diagnose and therapy reason. Results: The departments participating in both studies included and admitted patients respectively. Correspondingly 31% and 32% of the admitted patients were treated with antimicrobials. Distribution of women/men and adults/children were similar both years. The numbers of therapies were 3377 (54% CAI, 27% HAI, 19% prophylaxis) and 3523 (52% CAI, 28% HAI, 20% prophylaxis) respectively. A large fraction of women with cystitis were treated with fluoroquinolones (20% resp. 24%). The most common indication for cephalosporins (DDD) was community acquired pulmonary infections. Duration of peri-operative prophylaxis was more than 24 hours in about 40% of the cases. Conclusions: Demographic data from the two study periods were congruent. Analysis of antimicrobial use in relation to diagnose and therapy reason is an important tool to identify problem areas. Although the PPS method is time consuming, it was successfully introduced resulting in one of the largest surveys in Europe of antimicrobial hospital treatment. Diagnose groups Central nervous system Ophthalmic infections Mouth and throat Upper respiratory tract Bronchitis Pulmonary infections Cardiovascular system Upper gastrointestinal tract Lower gastrointestinal tract Infectious gastrointestinal diseases Liver/bile duct/pancreas/spleen Skin and soft tissue Bone and joint Lower urinary tract infection Upper urinary tract infection Genital infections Septicaemia, primary Un-specified indication, fever Indication unclear PPS No. of admitted patients No. of treated patients Distribution women / men Proportion children (31%) 49.5 / 50.5% 5.6% (32%) 49.8 / 50.2% 5.2% No. of therapies No of antibiotics No. of DDD´s DDD/100 admitted PPS Community acquired54%52% Hospital acquired27%28% Prophylaxis19%20%